SCHEMBL3628342

SCHEMBL3628342

CCCNc1ccccc1N

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.47
MAPT P10636 5/20 0.45
HTT P42858 2/20 0.45
GAA P10253 4/20 0.43
KDM4E B2RXH2 4/20 0.43
ALDH1A1 P00352 3/20 0.43
CYP1A2 P05177 2/20 0.43
CYP2C9 P11712 2/20 0.43
CYP2C19 P33261 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
LMNA P02545 1/20 0.43
CYP2D6 P10635 1/20 0.43
TDP1 Q9NUW8 2/20 0.42
APP P05067 2/20 0.42
TLR8 Q9NR97 1/20 0.41
ALOX15 P16050 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
TP53 P04637 1/20 0.41
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29922465 1.00 IDO1 (0.47) IDO1MAPTHTTGAAKDM4E
Ammonia Solution, Strong SCHEMBL3079012 0.98 IDO1 (0.46) IDO1MAPTHTTGAAKDM4E
SCHEMBL659537 0.88 TLR8 (0.54) MAPTHTTGAAKDM4EALDH1A1
SCHEMBL29636805 0.88 TLR8 (0.54) MAPTHTTGAAKDM4EALDH1A1
SCHEMBL6201094 0.86 MAPT (0.52) MAPTHTTGAAKDM4EALDH1A1
SCHEMBL1170549 0.86 TLR8 (0.49) MAPTHTTALDH1A1CYP1A2CYP2C9
SCHEMBL29922455 0.86 TLR8 (0.49) MAPTHTTALDH1A1CYP1A2CYP2C9
SCHEMBL9011310 0.84 L3MBTL1 (0.48) CYP1A2CYP2C9CYP2C19LMNATLR8
SCHEMBL8082845 0.84 L3MBTL1 (0.48) CYP1A2CYP2C9CYP2C19LMNATLR8
SCHEMBL21799596 0.84 L3MBTL1 (0.48) CYP1A2CYP2C9CYP2C19LMNATLR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260097034-A1 METALLOENZYME INHIBITOR COMPOUNDS CORXEL PHARMACEUTICALS HONG KONG LTD (HK) 2026-04-09 US disclosed
US-12458642-B2 Metalloenzyme inhibitor compounds CORXEL PHARMACEUTICALS HONG KONG LIMITED (HK) 2025-11-04 US disclosed
EP-3623398-B1 RESIN COMPOSITION COMPRISING A MODIFIED BLOCK COPOLYMER AND METHOD FOR PRODUCING MODIFIED BLOCK COPOLYMER ASAHI CHEMICAL IND (JP) 2024-08-28 EP disclosed
EP-4311577-A2 METALLOENZYME INHIBITOR COMPOUNDS Ji Xing Pharmaceuticals Hong Kong Limited (HK) 2024-01-31 EP disclosed
EP-3562487-B1 METALLOENZYME INHIBITOR COMPOUNDS JI XING PHARMACEUTICALS HONG KONG LTD (HK) 2023-11-29 EP disclosed
EP-3562487-B1 METALLOENZYME INHIBITOR COMPOUNDS JI XING PHARMACEUTICALS HONG KONG LTD (HK) 2023-11-29 EP disclosed
CN-110603273-B Modified block copolymer, method for producing modified block copolymer, and resin composition 旭化成株式会社 2022-10-14 CN disclosed
US-20210322409-A1 METALLOENZYME INHIBITOR COMPOUNDS SELENITY THERAPEUTICS (BERMUDA), LTD. (BM) 2021-10-21 US disclosed
US-11124593-B2 Modified block copolymer, method for producing modified block copolymer, and resin composition ASAHI KASEI KABUSHIKI KAISHA (JP) 2021-09-21 US disclosed
US-11040034-B2 Metalloenzyme inhibitor compounds PHASEBIO PHARMACEUTICALS, INC. (US) 2021-06-22 US disclosed
EP-0237929-B1 3,5-DISUBSTITUTED PYROCATECHOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1993-06-02 EP disclosed
EP-0431756-A2 Polyol and rigid polyurethane foam MITSUI TOATSU CHEMICALS, Inc. (JP) 1991-06-12 EP disclosed
EP-0348825-A2 High molecular weight poly-(toluenediamine aramides) and a method for their preparation AIR PRODUCTS AND CHEMICALS, INC. (US) 1990-01-03 EP disclosed
EP-0126231-B1 VINYLPHENYL BENZIMIDAZOLE DERIVATIVES, THEIR POLYMERS, THEIR PREPARATION AND USE Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1989-12-20 EP disclosed
US-4885356-A HIGH STRENGTH, TOUGHNESS AIR PRODUCTS AND CHEMICALS, INC. (US) 1989-12-05 US disclosed
EP-0237929-A1 3,5-Disubstituted pyrocatechol derivatives F. HOFFMANN-LA ROCHE AG (CH) 1987-09-23 EP disclosed
US-4533678-A BENZIMIDAZOLYLSTYRENE POLYMERS ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1985-08-06 US disclosed
EP-0126231-A2 Vinylphenyl benzimidazole derivatives, their polymers, their preparation and use Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1984-11-28 EP disclosed
US-4311700-A ANTIULCER, GASTROINTESTINAL DISORDERS BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1982-01-19 US disclosed
EP-0024582-A1 Benzodiazepinones, process for their preparation and pharmaceutical compositions containing them Byk Gulden Lomberg Chemische Fabrik GmbH (DE) 1981-03-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12458642-B2 Metalloenzyme inhibitor compounds CYP11B2, CYP11B1, HSD11B2 IDO1 935/4885MAPT 2593/4885HTT 4352/4885
US-20260097034-A1 METALLOENZYME INHIBITOR COMPOUNDS CPN1, TPP1, DPP4 IDO1 678/4885MAPT 2173/4885HTT 3593/4885
US-20210322409-A1 METALLOENZYME INHIBITOR COMPOUNDS SOD1, RNASE1, FECH IDO1 1842/4885MAPT 2388/4885HTT 2542/4885
US-11040034-B2 Metalloenzyme inhibitor compounds SOD1, RNASE1, FECH IDO1 1842/4885MAPT 2388/4885HTT 2542/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.